Penicillin V Potassium for Oral Solution — Class II drug recall D-0294-2022
Terminated recall by Teva Pharmaceuticals USA, reported 2021-12-29, distributed nationwide. Subpotent
| Recall number | D-0294-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Parsippany, NJ, United States |
| Recall initiated | 2021-12-16 |
| Classified | 2021-12-23 |
| Reported by FDA | 2021-12-29 |
| Terminated | 2022-11-04 |
| Distributed | Nationwide (US) |
| Reason classes | potency |
| NDC | 00093-4125-73, 00093-4125-74 |
| Lot numbers | 35446318B, 35446365A, 35447040A, 35447947A, 35447948B |
| Expiration dates | 2022-03, 2022-05, 2022-08, 2023-03 |
Product
Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) 100 mL (NDC 00093-4125-73) and b) 200 mL (NDC 00093-4125-74) (when mixed) bottles, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454
Reason for recall
Subpotent
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0294-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.